Date: 2015-10-02
Type of information: Capital increase
Company: Galapagos (Belgium)
Investors:
Amount: €1.2 million
Funding type: capital increase
Planned used:
Others: * On October 2, 2015, Galapagos announced a share capital increase arising from warrant exercises. As a result of warrant exercises, Galapagos issued 118,260 new ordinary shares on 25 September 2015, for a total capital increase (including issuance premium) of €1,198,094.00. Pursuant to the rules of the warrant exercise program of Galapagos\' Executive Committee adopted in 2013, Executive Committee members automatically are committed to exercise a minimum number of warrants, subject to certain conditions. Accordingly, CEO Onno van de Stolpe exercised 10,000 warrants and two other Executive Committee members exercised an aggregate amount of 5,000 warrants. In accordance with Belgian transparency legislation, Galapagos notes that its total share capital currently amounts to €211,045,322.22; the total number of securities conferring voting rights is 39,012,842, which is also the total number of voting rights (the \"denominator\"), and all securities conferring voting rights and all voting rights are of the same category. The total number of rights (warrants) to subscribe to not yet issued securities conferring voting rights is 2,869,192, which equals the total number of voting rights that may result from the exercise of these warrants. Galapagos does not have any convertible bonds or shares without voting rights outstanding.
Therapeutic area:
